HomeInsights52 Week High Stocks

Glaxosmithkline Pharmaceuticals Ltd 52 Week High

Glaxosmithkline Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.5 Cr

Volume transacted

stocks purchased

1.8 K

stocks traded

Last Updated time: 05 Nov 13:54 PM

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

YEARHIGH

3087.95

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week HIGH of Glaxosmithkline Pharmaceuticals Ltd is ₹ 3087 as of 04 Nov 24.

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20242612.7
01 Nov 20242729.7
31 Oct 20242719.8
30 Oct 20242677.25
29 Oct 20242629.75
28 Oct 20242642.35
25 Oct 20242586.7
24 Oct 20242618.5
23 Oct 20242630.85
22 Oct 20242581.9

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 202410:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 202416:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 202410:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 202412:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 202410:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 202413:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Glaxosmithkline Pharmaceuticals Ltd

What is the significance of Glaxosmithkline Pharmaceuticals Ltd reaching its 52-week high?

Glaxosmithkline Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Glaxosmithkline Pharmaceuticals Ltd 52-week high?

Investors monitor Glaxosmithkline Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Glaxosmithkline Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Glaxosmithkline Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Glaxosmithkline Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Glaxosmithkline Pharmaceuticals Ltd at its 52-week high?

Before investing in Glaxosmithkline Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Glaxosmithkline Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Glaxosmithkline Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*